What is the prevalence of PEPCK Deficiency?

PEPCK Deficiency is an extremely rare genetic disorder that affects the body's ability to produce an enzyme called phosphoenolpyruvate carboxykinase (PEPCK). This enzyme plays a crucial role in the process of gluconeogenesis, which is the production of glucose from non-carbohydrate sources in the body.

Due to its rarity, the prevalence of PEPCK Deficiency is not well-documented. However, it is estimated that only a few dozen cases have been reported worldwide. The disorder is inherited in an autosomal recessive manner, meaning that both parents must carry a mutated gene for their child to be affected.

PEPCK Deficiency typically manifests in early infancy, with symptoms including severe hypoglycemia (low blood sugar), lactic acidosis, and failure to thrive. The condition can lead to developmental delays, intellectual disability, and other complications if not properly managed.

Diagnosis of PEPCK Deficiency involves genetic testing to identify mutations in the PEPCK gene. Treatment options are limited and mainly focus on managing symptoms, such as providing a carefully controlled diet and monitoring blood glucose levels.

Given its rarity, further research and awareness are needed to better understand the prevalence and impact of PEPCK Deficiency on affected individuals and their families.